Literature DB >> 2674261

Asthma mortality: what have we learned?

A S Buist1.   

Abstract

In this article, I have tried to present the complexity of the issues relating to asthma mortality. There are many unanswered questions and few straightforward answers. It is appropriate that we be concerned that mortality rates are apparently increasing despite the availability of better antiasthma medications and that we identify the key research studies that will allow us to answer these complex questions. At the same time, we should take this opportunity to increase our educational efforts. For the health professionals these efforts should be directed toward improving the accuracy of diagnosis and appropriateness of management in asthma. For the lay public, the efforts should be directed toward increasing the awareness of the many faces of asthma.

Entities:  

Mesh:

Year:  1989        PMID: 2674261     DOI: 10.1016/0091-6749(89)90408-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  2 in total

Review 1.  Clinical management of asthma in the 1990s. Current therapy and new directions.

Authors:  P Jain; J A Golish
Journal:  Drugs       Date:  1996       Impact factor: 9.546

2.  The role of ozone exposure in the epidemiology of asthma.

Authors:  J R Balmes
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.